JUNIUS DANIEL M — SEC insider filings
SEC reporting owner CIK 1094159. 36 insider filings on record with FilingPulse; latest filed 2026-11-05.
Transaction summary — filings shown
Covers all 36 filings on record, filed 2020-08-21 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 50,000 shares, $84,200 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 10 legs across 8 filings — 19,638 shares, $10,044,449 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 54.
- Largest priced transaction: sale of 2,402 shares @ $679.58 ($1,632,355) in IDEXX LABORATORIES INC /DE, filed 2021-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IDEXX LABORATORIES INC /DE (IDXX) | Director | 29 | — | 10 legs · 19,638 sh · $10,044,449 | 48 |
| GLYCOMIMETICS INC (GLYC) | Director | 7 | 2 legs · 50,000 sh · $84,200 | — | 6 |
Insider filings — JUNIUS DANIEL M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-05 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Sale (S): 700 @ $705.78 · Sale (S): 500 @ $701.68 | EDGAR |
| 2026-05-14 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 525 (derivative) @ $0 · Grant/award (A): 234 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 257 @ $0 · Option exercise (M): 257 (derivative) | EDGAR |
| 2025-05-14 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 1,404 @ $245.79 · Option exercise (M): 1,279 @ $283.59 · Sale (S): 2,683 @ $506.41 · Option exercise (M): 1,404 (derivative) @ $0 · Option exercise (M): 1,279 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 262 @ $0 · Option exercise (M): 262 (derivative) @ $0 · Grant/award (A): 600 (derivative) @ $0 · Grant/award (A): 257 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 609 (derivative) @ $0 · Grant/award (A): 262 (derivative) @ $0 | EDGAR |
| 2024-05-01 | 4 | GLYCOMIMETICS INC (GLYC) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | GLYCOMIMETICS INC (GLYC) | Grant/award (A): 5,209 @ $3 | EDGAR |
| 2024-02-01 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 14 @ $521.03 | EDGAR |
| 2023-11-01 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 19 @ $396.39 | EDGAR |
| 2023-08-01 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 14 @ $552.78 | EDGAR |
| 2023-05-22 | 4 | GLYCOMIMETICS INC (GLYC) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 645 (derivative) @ $0 · Grant/award (A): 257 (derivative) | EDGAR |
| 2023-05-11 | 4 | GLYCOMIMETICS INC (GLYC) | Purchase (P): 30,000 @ $1.56 | EDGAR |
| 2023-05-02 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 13 @ $492.16 | EDGAR |
| 2023-02-17 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 2,187 @ $206.62 · Sale (S): 2,187 @ $511.68 · Option exercise (M): 2,187 (derivative) | EDGAR |
| 2023-02-01 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 14 @ $482.95 | EDGAR |
| 2022-12-07 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 3,046 @ $160.28 · Sale (S): 3,046 @ $424.91 · Option exercise (M): 3,046 (derivative) | EDGAR |
| 2022-11-18 | 4 | GLYCOMIMETICS INC (GLYC) | Purchase (P): 20,000 @ $1.87 | EDGAR |
| 2022-11-01 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 18 @ $364.28 | EDGAR |
| 2022-08-02 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 16 @ $399.18 | EDGAR |
| 2022-05-20 | 4 | GLYCOMIMETICS INC (GLYC) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2022-05-13 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 344 (derivative) · Grant/award (A): 945 (derivative) | EDGAR |
| 2022-05-03 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 15 @ $430.48 | EDGAR |
| 2022-02-01 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 13 @ $489.05 | EDGAR |
| 2021-11-02 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 10 @ $666.14 | EDGAR |
| 2021-08-12 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 2,402 @ $85 · Sale (S): 2,402 @ $679.58 · Option exercise (M): 2,402 (derivative) | EDGAR |
| 2021-08-03 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 10 @ $678.53 | EDGAR |
| 2021-05-27 | 4 | GLYCOMIMETICS INC (GLYC) | Grant/award (A): 5,250 @ $0 · Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2021-05-24 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 2,500 @ $85 · Sale (S): 2,500 @ $539.57 · Option exercise (M): 2,500 (derivative) | EDGAR |
| 2021-05-14 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 224 (derivative) · Grant/award (A): 723 (derivative) | EDGAR |
| 2021-05-04 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 11 @ $548.99 | EDGAR |
| 2021-02-24 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 898 @ $79.54 · Option exercise (M): 1,000 @ $85 · Sale (S): 10 @ $539.19 · Sale (S): 1,888 @ $538.57 · Option exercise (M): 898 (derivative) · Option exercise (M): 1,000 (derivative) | EDGAR |
| 2021-02-03 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 13 @ $478.68 | EDGAR |
| 2020-11-02 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/award (A): 15 @ $424.82 | EDGAR |
| 2020-08-21 | 4 | IDEXX LABORATORIES INC /DE (IDXX) | Option exercise (M): 3,722 @ $63.95 · Sale (S): 3,722 @ $382.61 · Option exercise (M): 3,722 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1094159 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs